Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.

作者: Duan Wang , Tianhang Xie , Jin Xu , Haoyang Wang , Weinan Zeng

DOI: 10.1038/SREP30220

关键词:

摘要: Accumulating evidences have indicated that the functional -94 ins/del ATTG polymorphism in promoter region of human nuclear factor-kappa B1 (NFKB1) gene may be associated with cancer risk. However, some studies yielded conflicting results. To clarify precise association, we performed a comprehensive meta-analysis 42 case-control involving 43,000 subjects (18,222 cases and 24,778 controls). The overall results suggested had decreased risk for cancer, reaching significant levels five genetic models (dominant model: OR = 0.86, 95% CI = 0.79-0.95, P = 0.002; recessive OR = 0.84, CI = 0.74-0.94, P = 0.003; homozygous OR = 0.77, CI = 0.66-0.90, P = 0.001; heterozygous OR = 0.90, CI = 0.83-0.98, P = 0.011; allelic OR = 0.89, CI = 0.83-0.96, P = 0.002). Furthermore, could confer or increased development among Asians Caucasians, respectively. Additionally, stratification analysis revealed association between variant oral, ovarian, nasopharyngeal Asians. After adjusted p values using Benjamini-Hochberg false discovery rate method to account multiple comparisons, these associations remained.

参考文章(61)
Wei Qiao, Xuhui Zhou, Chenglin Zhang, Xiyi Li, Menghong Sun, NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population. International Journal of Clinical and Experimental Medicine. ,vol. 8, pp. 1420- 1423 ,(2015)
Yehua Liu, Fuman Qiu, Lei Yang, Rongrong Yang, Xiaorong Yang, Dongsheng Huang, Wenxiang Fang, Lisha Zhang, Qingping Jiang, Lan Zhang, Yifeng Zhou, Jiachun Lu, Polymorphisms of NFκB1 and IκBα and Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility BioMed Research International. ,vol. 2015, pp. 362542- 362542 ,(2015) , 10.1155/2015/362542
Kathrin Riemann, Lucie Becker, Henrike Struwe, Holger Nückel, Ulrich Dührsen, Hakan Alakus, Günter Winde, Markus Neuhäuser, Herbert Rübben, Klaus J. Schmitz, Jeremias Wohlschlaeger, Kurt W. Schmid, Winfried Siffert, No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenetics and Genomics. ,vol. 16, pp. 783- 788 ,(2006) , 10.1097/01.FPC.0000230414.74726.F6
Ferda Sevimli Burnik, Şuayib Yalçın, NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy. ,vol. 55, pp. 381- 385 ,(2009) , 10.1159/000237744
Wenshu Chen, NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target Frontiers in Bioscience. ,vol. 16, pp. 1172- 1185 ,(2011) , 10.2741/3782
Pengchao Li, Jinbao Gu, Xiao Yang, Hongzhou Cai, Jun Tao, Xuejian Yang, Qiang Lu, Zengjun Wang, Changjun Yin, Min Gu, Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0071604
Xiao Yang, Pengchao Li, Jun Tao, Chao Qin, Qiang Cao, Jinbao Gu, Xiaheng Deng, Jun Wang, Xuzhong Liu, Zijie Wang, Bian Wu, Min Gu, Qiang Lu, Changjun Yin, Association between NFKB1 −94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis Comparative and Functional Genomics. ,vol. 2014, pp. 612972- 612972 ,(2014) , 10.1155/2014/612972
Shu-Chun Lin, Chung-Ji Liu, Wen-I Yeh, Man-Tin Lui, Kuo-Wei Chang, Che-Shoa Chang, Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Letters. ,vol. 243, pp. 47- 54 ,(2006) , 10.1016/J.CANLET.2005.11.019
Madhuri Koti, Robert J Gooding, Paulo Nuin, Alexandria Haslehurst, Colleen Crane, Johanne Weberpals, Timothy Childs, Peter Bryson, Moyez Dharsee, Kenneth Evans, Harriet E Feilotter, Paul C Park, Jeremy A Squire, Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer BMC Cancer. ,vol. 13, pp. 549- 549 ,(2013) , 10.1186/1471-2407-13-549